Drug-eluting stents for treating coronary artery disease
Closed for comments This consultation ended on at Request commenting lead permission
4 Committee members
This topic was considered by NICE's medical technologies advisory committee, which is a standing advisory committee of NICE.
Committee members are asked to declare any interests in the technology to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of each committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
NICE also recruited clinical experts and specialist committee members for this topic.
Specialist committee members
Ferrah Choudhary
Consultant interventional cardiologist and PFO service lead, Manchester University Hospitals NHS Foundation Trust
Joel Giblett
Cardiologist and honorary senior clinical lecturer, Liverpool Heart and Chest Hospital
Stephen Hoole
Affiliated associate professor, University of Cambridge, and consultant interventional cardiologist, Royal Papworth Hospital NHS Foundation Trust
Adnan Nadir
Consultant cardiologist coronary and structural heart interventions, Queen Elizabeth Hospital, Birmingham
Ian Purcell
Consultant interventional cardiologist, Freeman Hospital, Newcastle upon Tyne
Sudhir Rathore
Consultant interventional cardiologist, Frimley Health NHS Foundation Trust, and honorary reader, University of Surrey
Clinical experts
Dawn Adamson
Consultant cardiologist, University Hospitals Coventry & Warwickshire
Mamas Mamas
Professor of cardiology, Keele University, and honorary consultant interventional cardiologist, Royal Stoke Hospital
Abdul Mozid
Consultant cardiologist, Yorkshire Heart Centre, Leeds Teaching Hospitals NHS Trust
ISBN: [to be added at publication]
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions